Effects of pemafibrate on metabolic parameters in patients with diabetes
Not Applicable
- Conditions
- Type 2 diabetes and hypertriglyceridemia
- Registration Number
- JPRN-UMIN000038160
- Lead Sponsor
- Akishima Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 27
Inclusion Criteria
Not provided
Exclusion Criteria
Patients having hepatic and renal dysfunction (serum levels of AST, ALT, and gamma-GTP >100 U/L and/or serum creatinine level >2.0 mg/dL)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method